"compound 23"
selective oral serine protease FXia inhibitor projected BID dosing in patients from 1.8k cmpd protease inh. screen + SBDD J. Med. Chem., Jun. 17, 2020 Novartis (NIBR), Basel, Switzerland
Molecules of the Month - July 2020
Molecules of the Month
- A-1331852
- dotinurad (FYU-981)
- X-165
- "compound 38a"
- HTL22562
- "compound 23"
- MGS0274
- LXE408
- "compound 2"
- AB680
- "compound 18"
- ETX0282
- "compound 6g"
- EC2629